Please login to the form below

Not currently logged in

Europe misses flu vaccine target for at-risk groups

Netherlands only country where coverage is at recommended level, says WHO

The majority of countries in Europe are lagging far behind the recommended uptake for influenza vaccine in at-risk groups.

According to the World Health Organization (WHO), of the countries where data was available only the Netherlands managed to ensure more than 75 per cent of its elderly population had adequate flu protection.

Countries almost at the 75 per cent target included the UK, Spain, Italy and Belgium, but right at the other end of the scale were Poland, Lithuania and Estonia, all of which had less than 20 per cent coverage.

This is despite a very real problem regarding influenza in the elderly, with 90 per cent of deaths related to seasonal influenza estimated to occur among those aged over 65. Flu is also likely to be more severe in older people and this population takes longer to recover.

In addition to its guidance for the elderly, the WHO also recommends pregnant women, people with chronic medical conditions, residents of institutions for disabled people, healthcare workers and small children should be offered the seasonal influenza vaccine.

However, national recommendations for these groups vary widely, and data is far more limited than in the elderly where 94 per cent of European countries have set levels to aim for.

This lack of national recommendations is a contributing factor to the low uptake, according to the WHO, along with lack of knowledge and poor access for some groups to the vaccine.

To overcome this, the WHO wants national vaccine recommendations to be reviewed and potentially include pregnant woman and a cost-benefit assessment of flu vaccination programmes carried out to highlight its economic positives.

The WHO said risk groups should be prioritised in locations with limited access to vaccines, but acknowledged it needs to work with member states to improve public perception of the flu vaccine.

22nd October 2012

From: Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...